Palliative care does not improve health-related quality of life among patients undergoing curative-intent surgery for upper gastrointestinal cancer, a study suggests.
Cancer death rates in the US have declined in recent years, but the declines vary by congressional district, a study suggests.
Adding HIPEC and mitomycin C to surgical resection improves locoregional control in patients with locally advanced colon cancer, a study suggests.
Patients with advanced cancer have better outcomes if they have high TMB prior to treatment with an ICI, new research suggests.
Adding bevacizumab to treatment with trifluridine-tipiracil improves outcomes in patients with refractory, metastatic colorectal cancer, a phase 3 study suggests.
A new study has revealed “stark” differences in cancer death rates between Asian patients and NHPI patients in the US, according to researchers.
Adagrasib produced responses in a phase 1/2 trial of patients with heavily pretreated, KRAS G12C-mutated solid tumors.
New research suggests that some cancer patients do not have their menstrual history documented and do not receive treatment for menstrual disturbances.
Patients with de novo metastatic cancer have seen modest improvements in survival over the last 3 decades.
Research has revealed regional disparities in outcomes for patients who are hospitalized with chemotherapy-related febrile neutropenia in the United States.
The incidence of esophageal cancer increased significantly from 2005 to 2019, but the mortality rate decreased.
Elevated levels of inflammatory biomarkers are associated with worse outcomes for patients with stage III colon cancer, a study suggests.
Compared with standard care, preoperative short-course RT followed by chemotherapy can decrease distant metastasis in patients with high-risk LARC.
Editorial board members for oncology-focused journals may sit on multiple editorial boards at the same time.
More than one-third of ASCO grants were awarded to researchers at 4 institutions.
Patients with cancer experienced symptoms of PTSD during the first year of the COVID-19 pandemic, a French study suggests.
A biopsychosocial screening program can provide clinical benefits for patients with cancer, a study suggests.
Larotrectinib prolongs survival when compared with non-TRK inhibitor standard care in adults with TRK fusion-positive cancers, a study suggests.
Compared with the general population, survivors of childhood and adolescent cancers have an increased risk of 6 major psychiatric disorders.
Postmenopausal cancer survivors have greater declines in physical function than cancer-free control individuals, a new study suggests.
Race and ethnicity are associated with delays or discontinuations of cancer treatment after COVID-19, but social determinants of health are not, a study suggests.
A decision support system called GI TARGET may help integrate precision medicine into routine care for patients with gastrointestinal cancer, according to researchers.
Extending adjuvant S-1 chemotherapy beyond 6 months after resection of pancreatic ductal adenocarcinoma does not improve outcomes, a real-world study suggests.
Awareness of factors that cause cancer is especially poor among people who reject vaccines, prefer alternative medicine, or believe conspiracy theories.
Synchronous multiple primary colorectal cancer can be classified into 3 subgroups according to the MMR and MSI status of each lesion, according to researchers.
Delivery of radiation to the celiac plexus can decrease pain and opioid use among patients with pancreatic cancer, a phase 2 study suggests.
Cancer patients with barriers to transportation have an increased risk of emergency department visits, cancer-specific mortality, and all-cause mortality, a new study suggests.
Screening colonoscopy may provide a small reduction in the risk of colorectal cancer and no reduction in the risk of death, a study suggests.
Researchers discovered a discrepancy between QT interval formulae used to assess heart rhythm and determine chemotherapy doses in a patient with leukemia.
A team of investigators examined the financial burden of breast, lung, colorectal, and prostate cancers for nonelderly adults with private insurance.
